13 November 2017
The government has proposed to increase funding for the state program “Development of Pharmaceutical and Medical Industry” by 6.38 million rubles in 2018-2020. This results from the amendments to the draft budget prepared for the second reading in the State Duma.
It means that, in 2018, the state may allocate for the program 101.22 million rubles; in 2019, 101.61 million rubles; and in 2020, 101.59 million rubles.
Earlier, Alexey Alekhin, the Head of Pharmaceutical and Medical industry Development Department of the Russian Ministry of Industry and Trade, said that, under the state program “Development of Pharmaceutical and Medical Industry in 2013-2020,” the government provides subsidies to enterprises to compensate for the costs of the development of medicinal products and medical devices, organization of substance manufacturing, and clinical trials.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Research calls for greater investment in Alzheimer’s clinical trials
03 May 2024
Stress impact on protein particle formation for monoclonal antibody formulation
03 May 2024
Health Ministry registered Russian drug for ankylosing spondylitis
02 May 2024
Production of finished drugs in Russia grew by 13.8%
02 May 2024